FAM135A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.763200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.111800E-01
Normal-vs-Stage2
3.359400E-01
Normal-vs-Stage3
8.969000E-01
Normal-vs-Stage4
1.992790E-01
Stage1-vs-Stage2
6.426000E-01
Stage1-vs-Stage3
5.217000E-01
Stage1-vs-Stage4
2.280600E-01
Stage2-vs-Stage3
2.316000E-01
Stage2-vs-Stage4
6.008400E-02
Stage3-vs-Stage4
1.313780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.002800E-01
Normal-vs-AfricanAmerican
4.142200E-01
Normal-vs-Asian
2.933000E-01
Caucasian-vs-AfricanAmerican
5.585800E-01
Caucasian-vs-Asian
2.957800E-01
AfricanAmerican-vs-Asian
8.995200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.521000E-01
Normal-vs-Female
2.745000E-01
Male-vs-Female
6.721800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.023600E-01
Normal-vs-Age(41-60Yrs)
2.803000E-01
Normal-vs-Age(61-80Yrs)
3.745200E-01
Normal-vs-Age(81-100Yrs)
2.127800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.239000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.752000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.068200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.894800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.704200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.585800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.536200E-01
Normal-vs-Daily Drinker
5.969200E-01
Normal-vs-Weekly Drinker
4.350000E-01
Normal-vs-Occasional Drinker
3.467200E-01
Normal-vs-Social Drinker
3.078800E-01
Non Drinker-vs-Daily Drinker
1.231450E-01
Non Drinker-vs-Weekly Drinker
6.102200E-01
Non Drinker-vs-Occasional Drinker
8.884200E-01
Non Drinker-vs-Social Drinker
7.016400E-01
Daily Drinker-vs-Weekly Drinker
4.149200E-01
Daily Drinker-vs-Occasional Drinker
1.951560E-01
Daily Drinker-vs-Social Drinker
2.693000E-01
Weekly Drinker-vs-Occasional Drinker
7.056800E-01
Weekly Drinker-vs-Social Drinker
8.708000E-01
Occasional Drinker-vs-Social Drinker
8.045800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.240600E-01
Normal-vs-Grade 2
1.004400E-01
Normal-vs-Grade 3
7.238000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.528400E-01
Grade 1-vs-Grade 3
8.351400E-01
Grade 1-vs-Grade 4
3.240600E-01
Grade 2-vs-Grade 3
6.173600E-01
Grade 2-vs-Grade 4
1.004400E-01
Grade 3-vs-Grade 4
7.238000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.955200E-01
Normal-vs-NonDiabetic
3.365000E-01
Diabetic-vs-NonDiabetic
1.169780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.882400E-01
Normal-vs-NoPancreatitis
3.804200E-01
Pancreatitis-vs-NoPancreatitis
4.109000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.401800E-01
Normal-vs-N1
3.369800E-01
N0-vs-N1
6.082200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.577400E-03
Normal-vs-TP53-NonMutant
4.703700E-03
TP53-Mutant-vs-TP53-NonMutant
9.803400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
